Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Breast cancer

  • Open Access
    From overtreatment to precision: a new clinical standard for DCIS management
    Schlomo Schneebaum
    Cancer Biology & Medicine June 2026, 23 (6) 785-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0010
  • Open Access
    Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors
    Di Shao, Tianjian Yu, Yi Xiao and Zhiming Shao
    Cancer Biology & Medicine June 2026, 23 (6) 925-945; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0611
  • Open Access
    Artificial intelligence in breast cancer: applications and advancements
    Jianbin Li and Zefei Jiang
    Cancer Biology & Medicine March 2026, 23 (3) 363-373; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0704
  • Open Access
    Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer
    Yaxin Zhao, Han Wang, Ying Wang, Yizhou Jiang, Xin Hu and Zhiming Shao
    Cancer Biology & Medicine March 2026, 23 (3) 374-391; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0691
  • Open Access
    Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors
    Mingzhu Liu, Qingxi Chen, Luoling Zhang, Yunxuan Zhou, Ning Wen, Jin Jin, Junchao Cai, Shicheng Su, Jiang Li and Qiyi Zhao
    Cancer Biology & Medicine March 2026, 23 (3) 392-417; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0775
  • Open Access
    Virtual histology imaging of lymph nodes via dynamic full-field optical coherence tomography and deep learning to differentiate metastasis
    Shuwei Zhang, Houpu Yang, Yiyin Zhang, Xiaoxian Li, Jin Zhao, Yuanyuan Zhang, Ping Xue, Hua Kang, Hongchuan Jiang, Wenhui Ren and Shu Wang
    Cancer Biology & Medicine March 2026, 23 (3) 418-429; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0747
  • Open Access
    Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study
    Jiaxian Miao, Qi Liu, Jianing Zhao, Shishun Fan, Shenwen Wang, Feng Ye, Si Wu, Jinze Li, Huirui Zhang, Meng Zhang, Hong Bu, Xiao Han, Lianghong Teng and Yueping Liu
    Cancer Biology & Medicine March 2026, 23 (3) 430-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0771
  • Open Access
    Artificial intelligence empowering precision diagnosis and treatment of breast cancer: advancing global clinical practice with regional insights
    Zefei Jiang
    Cancer Biology & Medicine March 2026, 23 (3) 311-313; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0018
  • Open Access
    Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, and artificial intelligence in advancing quality of care for patients worldwide
    Michael Gnant
    Cancer Biology & Medicine March 2026, 23 (3) 314-319; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0674
  • Open Access
    Precision immunotherapy for breast cancer: from biomarkers to clinical practice
    Jie Mei, Kai Yang, Xinkang Zhang, Xiang Huang and Yongmei Yin
    Cancer Biology & Medicine March 2026, 23 (3) 320-326; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0815

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • Cancer epidemiology (26)
  • Cancer immunology and immunotherapy (77)
  • Gastrointestinal cancer (38)
  • Gynecologic cancer (15)
  • Hematologic tumor and lymphoma (14)
  • Hepatobiliary and pancreatic cancer (27)
  • Lung cancer (21)
  • Breast cancer (38)
  • Top articles (20)

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire